Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment

Journal of Korean Medical Science

Volumn 22, Issue SUPPL., 2007, Pages

  Chan, Woo Park ^a   Kwang, Moon Yang ^a,b   Hye, Ok Kim ^a   Sung, Ran Hong ^a   Tae, Jin Kim ^a   Kyung, Taek Lim ^a   Ki, Heon Lee ^a   Inn, Soo Kang ^a  

^a Kwandong University College of Medicine   (South Korea)

^b Cheil General Hospital   (South Korea)

Author keywords

Borderline ovarian tumor; Conservative treatment; In vitro fertilization

Indexed keywords

EID: 36148999421     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.s.s134     Document Type: Article

References (23)

1. Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol 2000; 19: 69-75.
2. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 1993; 12: 120-7.
3. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol 1993; 50: 316-22.
4. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155: 217-24.
5. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG, Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-8.
6. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1204-11.
7. Parazzini F, Negri E, La Vecchia C, Moroni S, Polatti A, Chiaffarino F. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 1998; 68: 226-8.
8. Shushan A, Paltiel O, Schenker JG. Induction of ovulation and borderline ovarian cancer - the hormonal connection? Eur J Obstet Gynecol Reprod Biol 1999; 85: 71-4.
9. Abu-Jawdeh GM, Jacobs TW, Niloff J, Cannistra SA. Estrogen receptor expression is a common feature of ovarian borderline tumors. Gynecol Oncol 1996; 60: 301-7.
10. Madelenat P, Meneux E, Fernandez H, Uzan S, Antoine JM. Place de l'assistance à la procréation après traitement conservateur d'une tumeur ovarienne: enquête multicentrique française. 10eme Congrès de la Société Française d'Oncologie Gynécologique. Poitiers. France. 5-6 November 1999.
11. Fasouliotis SJ, Davis O, Schattman G, Spandorfer SD, Kligman I, Rosenwaks Z. Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report. Fertil Steril 2004; 82: 568-72.
12. Nijman HW, Burger CW, Baak JP, Schats R, Vermorken JB, Kenemans P. Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer 1992; 28: 1971-3.
13. Mantzavinos T, Kanakas N, Genatas C, Papadias K, Zourlas PA. Five years' follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Hum Reprod 1994; 9: 2032-3.
14. Hoffman JS, Laird L, Benadiva C, Dreiss R. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol 1999; 74: 515-8.
15. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-6.
16. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer 2001; 92: 320-5.
17. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20: 1331-45.
18. Camatte S, Morice P, Pautier P, Atallah D, Duvillard P, Castaigne D. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG 2002; 109: 376-80.
19. Attar E, Berkman S, Topuz S, Baysal B, Akhan S, Chambers JT. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micropapillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod 2004; 19: 1472-5.
20. Morice P, Camatte S, Wickart-Poque F, Rouzier R, Pautier P, Pomel C, Lhomme C, Haie-Meder C, Duvillard P, Castaigne D. Conservative management of malignant and borderline ovarian tumor. Bull Cancer 2002; 89: 1019-26.
21. Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003; 79: 1216-21.
22. Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 2001; 76: 999-1004.
23. Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000; 95: 541-7.